Australia Stock Exchange release from SINGULAR HEA : China-based JV Formed and 3Dicom trial at Macau Hospital
23/02/2022 23:00
Australia Stock Exchange release from SINGULAR HEA SHG.AX : China-based JV Formed and 3Dicom trial at Macau Hospital
Recent news on Singular Health
See all newsBrief: Singular Health Group Receives US$3.0M From State Of Florida For Medical Imaging Data Repository
Brief: Singular Health Announces FDA 510(K) Clearance For 3Dicom MD Cloud
Australia's Singular Health hits two-month high on FDA clearance for medical imaging tech
Brief: Singular Health Signs USD$1.3M Contract With Provider Network Solutions
Brief: Singular Health Seeks Trading Halt